Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,987 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells.
Hata T, Rajabi H, Takahashi H, Yasumizu Y, Li W, Jin C, Long MD, Hu Q, Liu S, Fushimi A, Yamashita N, Kui L, Hong D, Yamamoto M, Miyo M, Hiraki M, Maeda T, Suzuki Y, Samur MK, Kufe D. Hata T, et al. Among authors: yamamoto m. Cancer Res. 2019 Nov 15;79(22):5711-5722. doi: 10.1158/0008-5472.CAN-19-1034. Epub 2019 Sep 13. Cancer Res. 2019. PMID: 31519689 Free PMC article.
Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer.
Hata T, Rajabi H, Yamamoto M, Jin C, Ahmad R, Zhang Y, Kui L, Li W, Yasumizu Y, Hong D, Miyo M, Hiraki M, Maeda T, Suzuki Y, Takahashi H, Samur M, Kufe D. Hata T, et al. Among authors: yamamoto m. Mol Cancer Ther. 2019 Oct;18(10):1744-1754. doi: 10.1158/1535-7163.MCT-19-0156. Epub 2019 Jul 15. Mol Cancer Ther. 2019. PMID: 31308076 Free PMC article.
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Yasumizu Y, et al. Among authors: yamamoto m. Nat Commun. 2020 Jan 17;11(1):338. doi: 10.1038/s41467-019-14219-6. Nat Commun. 2020. PMID: 31953400 Free PMC article.
Targeting the human MUC1-C oncoprotein with an antibody-drug conjugate.
Panchamoorthy G, Jin C, Raina D, Bharti A, Yamamoto M, Adeebge D, Zhao Q, Bronson R, Jiang S, Li L, Suzuki Y, Tagde A, Ghoroghchian PP, Wong KK, Kharbanda S, Kufe D. Panchamoorthy G, et al. Among authors: yamamoto m. JCI Insight. 2018 Jun 21;3(12):e99880. doi: 10.1172/jci.insight.99880. eCollection 2018 Jun 21. JCI Insight. 2018. PMID: 29925694 Free PMC article.
Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Yasumizu Y, et al. Among authors: yamamoto m. Nat Commun. 2020 Feb 24;11(1):1095. doi: 10.1038/s41467-020-14808-w. Nat Commun. 2020. PMID: 32094369 Free PMC article.
Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment.
Morimoto Y, Fushimi A, Yamashita N, Hagiwara M, Bhattacharya A, Cheng J, Frost TC, Ahmad R, Daimon T, Huang L, Hata T, Takahashi H, Yamamoto M, Suzuki Y, DeCaprio JA, Kufe D. Morimoto Y, et al. Among authors: yamamoto m. Oncogene. 2022 Jul;41(27):3511-3523. doi: 10.1038/s41388-022-02361-3. Epub 2022 Jun 10. Oncogene. 2022. PMID: 35688945 Free PMC article.
12,987 results
You have reached the last available page of results. Please see the User Guide for more information.